Key Points

  • In contrast to most cannabis plays, Green Thumb is profitable with a growth catalyst unrelated to legalization.

  • Other key strengths further solidify this company’s status as one of the stronger cannabis plays.

  • As such, Green Thumb remains a strong choice for investors who are bullish on the cannabis trend.

  • 10 stocks we like better than Green Thumb Industries ›

Green Thumb Industries (OTC: GTBIF) has only pulled back slightly in the months following last April’s short-lived run-up among marijuana stocks. Yet while the shares have held fairly well, don’t assume this means the stock is fairly priced at present levels.

Rather, considering Green Thumb’s operating performance and other fundamentals, it’s arguably a stronger choice among investors bullish on eventual regulatory clarity regarding U.S. federal law and the commercial sale of cannabis products.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

Image source: Getty Images.

Why Green Thumb stands out

While most popular cannabis stocks are based in Canada, Green Thumb is based in Chicago and ranks as one of the more high-profile multistate operators (MSOs). MSOs own and operate marijuana businesses licensed at the U.S. state level. While Canada-based operators, still limited in their ability to enter the U.S. market, continue struggling to reach profitability, MSOs like Green Thumb have already demonstrated consistent profitability.

Green Thumb, for instance, has reported GAAP profitability since 2020. Alongside a demonstrated track record of profitability, the company has a catalyst in place that could significantly increase profitability going forward. Earlier this year, Green Thumb renegotiated its licensing deal with 50%-owned Rythm (NASDAQ: RYM). Now that it is paying a flat licensing fee for Rythm’s trademarks rather than a set percentage, the company has greater operating leverage. This could produce the sort of earnings growth that enables shares to double from current prices.

Additional catalysts to consider

Alongside the aforementioned strengths are a few more that could prove key in driving its shares’ next big move higher. For instance, Green Thumb is one of several MSOs that have received a conditional license, permitting it to operate within Texas’ upcoming legalized medical cannabis market.

The company also continues aggressively buying back stock, recently increasing its share repurchase program ceiling by $100 million, equivalent to around 6% of its total share count. Even as the stock seems pricey at 38.8 times forward earnings, Green Thumb’s perfect storm of bullish catalysts suggests that analysts underestimate the company’s further profitability. Again, if you want exposure to the marijuana legalization trend, MSOs like Green Thumb remain the stronger choice.

Should you buy stock in Green Thumb Industries right now?

Before you buy stock in Green Thumb Industries, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Green Thumb Industries wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $418,761!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,195,804!*

Now, it’s worth noting Stock Advisor’s total average return is 918% — a market-crushing outperformance compared to 208% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of July 4, 2026.

Thomas Niel has no position in any of the stocks mentioned. The Motley Fool recommends Green Thumb Industries. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Source link

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial, investment, or legal advice. Stock markets, real estate, and other financial instruments involve significant risks, and past performance does not guarantee future results. You should conduct your own research and/or seek advice from a licensed financial advisor before making any investment decisions. The website owner is not liable for any financial losses or damages arising from the use of the information presented here.

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *